| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/20/1994 | US5349112 Cyclic anti-tumor promoter compounds, compositions and methods for production and use |
| 09/20/1994 | US5349070 Salicylic acid-maltol conjugates |
| 09/20/1994 | US5349068 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents |
| 09/20/1994 | US5349066 Bifunctional linking compounds, conjugates and methods for their production |
| 09/20/1994 | US5349064 Production of pyrrolopyrimidines |
| 09/20/1994 | US5349061 O-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroarylmacrolides having immunosuppressive activity |
| 09/20/1994 | US5348979 Method of promoting nitrogen retention in humans |
| 09/20/1994 | US5348978 Angiotensin converting enzyme inhibitors |
| 09/20/1994 | US5348975 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity |
| 09/20/1994 | US5348974 Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders |
| 09/20/1994 | US5348968 Migraines |
| 09/20/1994 | US5348967 Diaminotrifluoromethylpyridine derivatives, process for their production and phospholipase A2 inhibitor containing them |
| 09/20/1994 | US5348966 Method for treating pyoderma and Sezary's syndrome using FK 506 and related compounds |
| 09/20/1994 | US5348965 N-substituted azaheterocyclic carboxylic acids |
| 09/20/1994 | US5348963 Method of screening for modulators of amyloid formation |
| 09/20/1994 | US5348962 Nervous system disorders; schizophrenia |
| 09/20/1994 | US5348959 Use of dicentrine and its derivatives for the treatment of hypertension, arrhythmia, thrombosis and atherosclerosis |
| 09/20/1994 | US5348958 Hetaryloxy-β-carbolines, and use as pharmaceutical agents for treating epilepsy and anxiety |
| 09/20/1994 | US5348956 Substituted cyclopropylamino-1,3,5-triazines |
| 09/20/1994 | US5348952 Antibiotics for antiinflammatory agents, degenerative diseases caused by proteolytic enzymes and respiratory system disorders |
| 09/20/1994 | US5348951 Cephalosporins |
| 09/20/1994 | US5348950 Platinum(II) complex and antitumor agent |
| 09/20/1994 | US5348949 Method of preparing N-oxo-tetrahydro-β-carbolines |
| 09/20/1994 | US5348946 Heteroanthracycline antitumor analogs |
| 09/20/1994 | US5348750 Enhanced flavors using menthone ketals |
| 09/20/1994 | US5348748 Pulsatile once-a-day delivery systems for minocycline |
| 09/20/1994 | US5348744 Antidiarrheal compositions containing loperamide hydrochloride and a saccharide |
| 09/20/1994 | US5348739 Combined anti-tumor therapy with interleukin-2 and histamine, analogs thereof or H2 -receptor agonists |
| 09/20/1994 | US5348738 Oral composition with active water insoluble polymer |
| 09/20/1994 | US5348729 Administering antagonists, measuring hormone level |
| 09/20/1994 | CA2119051A1 Phenoxyphenylacetic acid derivatives |
| 09/20/1994 | CA2119000A1 Formulation for use in smokers |
| 09/20/1994 | CA1332062C Sulfonamido derivatives inhibiting the aldose reductase enzyme system and pharmaceutical compositions containing them |
| 09/20/1994 | CA1332061C Benzofuranic compounds, process for their preparation, pharmaceutical compounds and cosmetics containing them, and their use |
| 09/20/1994 | CA1332057C Bicycloalkyl, tricycloalkyl, azabicycloalkyl and azatricycloalkyl amides |
| 09/20/1994 | CA1332044C Swine growth promotion |
| 09/19/1994 | CA2119175A1 Nucleic acid pharmaceuticals |
| 09/19/1994 | CA2119095A1 Heterotricyclically substituted phenyl-cyclohexane-carboxylic acid derivatives |
| 09/17/1994 | CA2118961A1 Novel 2-thiosubstituted carbapenems |
| 09/16/1994 | CA2118821A1 Therapeutic compounds |
| 09/15/1994 | WO1994020598A1 Eye care products containing a pheromone additive and method of using the same |
| 09/15/1994 | WO1994020528A1 Inhibitors of herpes viral ribonucleotide reductase |
| 09/15/1994 | WO1994020527A1 Compositions and methods for the treatment of immunomediated inflammatory disorders |
| 09/15/1994 | WO1994020520A1 Steroid derivatives, pharmaceutical compositions containing them, and their use as antibiotics or disinfectants |
| 09/15/1994 | WO1994020517A1 Gene transfer for treating a connective tissue of a mammalian host |
| 09/15/1994 | WO1994020516A1 New sulfated lyso-ganglioside derivatives |
| 09/15/1994 | WO1994020515A1 New o-sulfated gangliosides and lyso-ganglioside derivatives |
| 09/15/1994 | WO1994020508A1 Phosphonic acid derivatives |
| 09/15/1994 | WO1994020505A1 Crystalline ceftiofur free acid |
| 09/15/1994 | WO1994020504A1 2-acyloxycephem derivatives as elastase inhibitors |
| 09/15/1994 | WO1994020500A1 Spiroazacyclic derivatives as substance p antagonists |
| 09/15/1994 | WO1994020499A1 Benzylimidazopyridine derivatives as angiotensin ii receptor antagonists |
| 09/15/1994 | WO1994020498A1 Benzylimidazopyridine derivative as angiotensin ii receptor antagonist |
| 09/15/1994 | WO1994020497A1 Pyrrolo-pyridine derivatives |
| 09/15/1994 | WO1994020496A1 Heterocyclic compounds and their preparation and use |
| 09/15/1994 | WO1994020495A1 Heterocyclic compounds and their preparation and use |
| 09/15/1994 | WO1994020493A1 Method for preparing n-methyl 2-(3-pyridyl) (1r,2r)-2-tetrahydrothiopyrancarbothioamide-1-oxide |
| 09/15/1994 | WO1994020492A1 Novel process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis |
| 09/15/1994 | WO1994020491A1 Benzopyranes as potassium channel openers |
| 09/15/1994 | WO1994020486A1 Method and apparatus for extracting taxol from source materials |
| 09/15/1994 | WO1994020485A1 Process for the preparation of 9-desoxotaxanes |
| 09/15/1994 | WO1994020484A1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 09/15/1994 | WO1994020483A1 Process to derivatives of piperizinylcamphorsulfonyl oxytocin antagonists |
| 09/15/1994 | WO1994020481A1 4-amino-2-(hetero)aryl-butanamides useful as 5-ht1a-antagonists |
| 09/15/1994 | WO1994020478A1 Hydroxymethyl furazane carboxylic acid derivatives and their use in the treatment of cardio-vascular conditions |
| 09/15/1994 | WO1994020472A1 Heterocyclic compounds, their use and preparation |
| 09/15/1994 | WO1994020471A1 Quinolone derivatives as dopamine d4 ligands |
| 09/15/1994 | WO1994020470A1 4-hydroxy-3-nitro-1,2-dihydroquinolin-2-ones and the use thereof as excitatory amino acid and glycine receptor antagonists |
| 09/15/1994 | WO1994020468A1 4-aminopyridines, their production and use as an antithrombosis agent |
| 09/15/1994 | WO1994020467A1 New 4-aminopyridines, process for preparing the same and medicaments containing the same |
| 09/15/1994 | WO1994020466A1 Novel 2-phenoxy ethylamine derivatives, their preparation and their therapeutical use |
| 09/15/1994 | WO1994020465A1 Indole derivatives as antagonists of excitatory amino acids |
| 09/15/1994 | WO1994020463A1 Novel distamycin analogues |
| 09/15/1994 | WO1994020459A2 Pyrrolo-pyridine derivatives as dopamine receptor ligands |
| 09/15/1994 | WO1994020455A1 Styryl derivatives, their preparation and use as pde-iv inhibitors |
| 09/15/1994 | WO1994020454A1 New derivatives of glutamic and aspartic acids, a method of preparing them, and their use as drugs for enhancing memory and learning |
| 09/15/1994 | WO1994020449A1 Salts of 2-(3-benzoylphenyl)propionic acid with achiral and chiral organic bases and pharmaceutical compositions thereof |
| 09/15/1994 | WO1994020446A1 Trisubstituted phenyl derivatives as phosphodiesterase inhibitors and processes for their preparation |
| 09/15/1994 | WO1994020146A1 Recombinant adenoviruses and use thereof in gene therapy for treating eye diseases |
| 09/15/1994 | WO1994020143A1 Optical isomerization inhibitor |
| 09/15/1994 | WO1994020133A1 Supplemented and unsupplemented tissue sealants, methods of their production and use |
| 09/15/1994 | WO1994020119A1 Therapeutic compositions containing a lithium compound and silica |
| 09/15/1994 | WO1994020117A1 Method of treating eye disorders with silicone/fluorosilicone copolymer oil |
| 09/15/1994 | WO1994020116A1 Artificial primers for glycogen synthesis |
| 09/15/1994 | WO1994020112A1 Reduction of boar odor in meat |
| 09/15/1994 | WO1994020111A1 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| 09/15/1994 | WO1994020110A1 Use of antiepileptics such as carbamazepine and oxcarbazepine for treating aids-related neural disorders |
| 09/15/1994 | WO1994020109A1 Use of 2h-1,2,4-benzothiadiazine 3(4h)-one 1,1 dioxide derivatives as non-competitive nmda receptor antagonists |
| 09/15/1994 | WO1994020108A1 Use of lamotrigine for treating aids-related neural disorders |
| 09/15/1994 | WO1994020107A1 Rejection inhibitor for transplants and il-1 production inhibitor |
| 09/15/1994 | WO1994020105A1 Interleukin-1 inhibitor |
| 09/15/1994 | WO1994020104A1 15-substituted 4-azasteroids |
| 09/15/1994 | WO1994020103A1 Use of riluzole for treating aids-related neural disorders |
| 09/15/1994 | WO1994020102A2 Medicament for treating or preventing cerebrovascular diseases |
| 09/15/1994 | WO1994020101A1 Antitumor compositions and methods of treatment |
| 09/15/1994 | WO1994020100A1 Method for treating emotional or mental illness and emotional or mental illness concomitant with seizures |
| 09/15/1994 | WO1994020099A1 3,4-diarylchromans for treatment of dermatitis |
| 09/15/1994 | WO1994020098A1 Methods for inhibiting bone loss with 3,4-diarylchroman |
| 09/15/1994 | WO1994020097A1 Use of, and method of treatment using, carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation |
| 09/15/1994 | WO1994020096A1 Method of employing carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation |